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Abstract
Background: We set out to determine the relative roles of stigma versus health systems in non-uptake of
prevention of mother to child transmission (PMTCT) of HIV-1 interventions: we conducted cross-sectional
assessment of all consenting mothers accompanying infants for six-week immunizations.
Methods: Between September 2008 and March 2009, mothers at six maternal and child health clinics in Kenya’s
Nairobi and Nyanza provinces were interviewed regarding PMTCT intervention uptake during recent pregnancy.
Stigma was ascertained using a previously published standardized questionnaire and infant HIV-1 status
determined by HIV-1 polymerase chain reaction.
Results: Among 2663 mothers, 2453 (92.1%) reported antenatal HIV-1 testing. Untested mothers were more likely
to have less than secondary education (85.2% vs. 74.9%, p = 0.001), be from Nyanza (47.1% vs. 32.2%, p < 0.001)
and have lower socio-economic status. Among 318 HIV-1-infected mothers, 90% reported use of maternal or infant
antiretrovirals. Facility delivery was less common among HIV-1-infected mothers (69% vs. 76%, p = 0.009) and was
associated with antiretroviral use (p < 0.001). Although internal or external stigma indicators were reported by
between 12% and 59% of women, stigma was not associated with lower HIV-1 testing or infant HIV-1 infection
rates; internal stigma was associated with modestly decreased antiretroviral uptake. Health system factors
contributed to about 60% of non-testing among mothers who attended antenatal clinics and to missed
opportunities in offering antiretrovirals and utilization of facility delivery. Eight percent of six-week-old HIV-1-
exposed infants were HIV-1 infected.
Conclusions: Antenatal HIV-1 testing and antiretroviral uptake was high (both more than 90%) and infant HIV-1
infection risk was low, reflecting high PMTCT coverage. Investment in health systems to deliver HIV-1 testing and
antiretrovirals can effectively prevent infant HIV-1 infection despite substantial HIV-1 stigma.
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Background
Interventions for the prevention of mother to child
transmission (PTMCT) of HIV-1 have the potential to
almost eliminate paediatric HIV-1, with effective regi-
mens resulting in a transmission risk of less than 2%
[1]. However, the impact of the most effective PMTCT
intervention is only as good as population coverage. A
highly effective intervention, such as highly active antire-
troviral therapy, which can decrease mother to child
transmission to about 1%, will be of no benefit to HIV-
1-infected women who are not diagnosed with HIV-1.
In 2010, the World Health Organization (WHO) and
the Joint United Nations Programme on HIV/AIDS
(UNAIDS) estimated that only 56% of HIV-1-infected
women accessed PMTCT interventions in Africa, where
maternal HIV-1 prevalence is highest [2]. Diagnosis of
maternal HIV-1 during pregnancy has been a major bot-
tleneck to delivering interventions in PMTCT
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Saharan Africa, HIV-1 testing was available to just over
a third of pregnant women, a considerable but still
inadequate improvement from 8% reported seven years
earlier [3]. Among women offered antenatal HIV-1 test-
ing, acceptance rates of between 55% and 99.8% are
reported [4-6]. Women may decline testing because they
wish to consult their partners [7-10]. Others may refuse
HIV-1 testing following insufficient counselling as they
perceive few benefits of testing [11,12]. Opt-out HIV-1
testing overcomes these barriers by routinizing HIV-1
testing within antenatal clinics (ANCs) [13,14].
Following HIV-1 testing, women may not inform their
partners of positive HIV-1 test results, fearing stigmati-
zation, abandonment or domestic violence [8,15,16].
Additionally, women remain concerned that their diag-
noses will not remain secret [17]. HIV-related discrimi-
nation can lead to social isolation. As a result, women
may elect to not use ANC services at the site where
they received HIV-1 testing, decline facility delivery, or
fail to take the antiretrovirals to avoid inadvertent dis-
closure [18,19].
To maximally decrease paediatric HIV-1 infections, it
is essential to assess coverage of services and infant
HIV-1 outcomes and to identify barriers to uptake of
PMTCT interventions. Barriers may be stigma related or
service provision related. It is critical to determine the
relative role of each of these potential barriers because
the approach to improving programmes would differ
based on which is most important. If stigma is the most
influential barrier, community efforts to decrease stigma
would be critical. Conversely, if systems are more
important, focusing on better service delivery would
yield effectiveness. In Kenya, more than 90% of mothers
take their infants for routine immunizations at six weeks
[20]. To determine barriers to uptake of PMTCT inter-
ventions, we conducted a study among all mothers
bringing their infants for six-week immunizations. This
approach to evaluation allowed us to obtain information
on mothers who either did or did not access PMTCT
services as part of their recent pregnancy care.
Methods
Study setting and population
This was a cross-sectional study of all women attending
six public sector maternal and child health (MCH)
clinics in Kenya for routine infant six-week immuniza-
tions: four in Nairobi at Dandora, Mathare North, Baba-
dogo and Kangemi city council clinics, and two in
western Kenya at Kisumu and Bondo District hospitals,
in Nyanza Province. The MCH clinics evaluated were
determined through purposive rather than random sam-
pling. We selected and compared MCH clinics in two
provinces with marked differences in HIV-1 prevalence:
Nyanza Province had an HIV-1 prevalence of 14.9%,
while in Nairobi, the prevalence was 8.8% [21,22].
At the MCH clinics evaluated, HIV-1 testing was rou-
tinely offered as part of antenatal care. The clinics addi-
tionally provided counselling on infant feeding,
antiretroviral drug use and advice on facility delivery as
part of routine PMTCT service. The choice of antiretro-
viral drugs was based on Kenyan Ministry of Health
guidelines at the time. Women with CD4 counts of ≤
350 cells/mm
3 or in WHO Stage 3 or 4 were recom-
mended to initiate highly active antiretroviral therapy.
The more efficacious short-course zidovudine regimen
and or single-dose nevirapine at onset of labour was
provided for mothers in WHO Stage 1 or 2 with CD4
counts of > 350 cells/mm
3. HIV-1-exposed infants were
offered HIV DNA PCR testing at the six-week immuni-
zation visit.
Recruitment and data collection
Mother-infant pairs attending the MCH clinic for rou-
tine six-week immunizations were recruited. After infant
weighing and vaccination, the study nurse explained the
study aims and procedures. Following written informed
consent, a questionnaire was administered to assess
maternal socio-demographic characteristics, stigma indi-
cators, ANC attendance, hospital delivery, and prior par-
ticipation in PMTCT programmes. Among HIV-1-
infected mothers, we additionally inquired on uptake of
antiretroviral drugs, infant feeding practices, reasons for
non-facility delivery, and non-use of antiretroviral drugs.
HIV-1-exposed infants were offered DNA PCR HIV-1
testing.
Stigma measures
Using standardized questions, which had been pre-
viously used in Tanzania, we evaluated four domains of
HIV-1 stigma, namely: fear of casual transmission and
refusal of contact with people living with HIV/AIDS;
value- and morality-related attitudes of blame, judge-
ment and shame for those living with HIV/AIDS; disclo-
sure of HIV test results; and enacted stigma or
discrimination [21]. These four domains provide a quan-
titative measure of HIV-1-related stigma and discrimina-
tion [22].
Data analysis
STATA version 10 (STATA Corp, College Station,
Texas, USA) was used to analyze data on testing at
antenatal clinics, facility delivery, use of maternal and
infant antiretrovirals, and infant feeding. We used Pear-
son’s Chi square and Fisher’se x a c tt e s t st oc o m p a r e
categorical variables, and t tests were used for continu-
ous variables. Multivariate analysis was conducted using
logistic regression with those covariates that were
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with testing at ANC, antiretroviral drug use and facility
delivery in the respective models.
Ethical approval
Approval for the study was obtained from Human Sub-
jects Division at the University of Washington and the
Kenyatta National Hospital Ethical and Research Com-
mittee. Authorization was also obtained from Nyanza’s
Provincial Medical Officer and the Medical Officer of
Health, Nairobi.
Results
Baseline characteristics
Between September 2008 and March 2009, 2700
mothers were enrolled at the six study sites, 908 (33.6%)
and 1792 (66.4%) from sites in Nyanza and Nairobi pro-
vinces, respectively. The mean age of mothers was 24
years (95% CI: 23.8-24.2). Most (86.2%) were married,
had less than secondary education (75.7%) and were not
employed (70.3%). Socio-economic status was assessed
by amount paid in monthly rent and ownership of a tel-
evision set and gas cooker. The mean monthly rent was
US$22.6 (95% CI: 21.9-23.2); less than 50% of mothers
owned a television set and about 10% owned a gas coo-
ker (Table 1).
HIV-1 testing at Antenatal Clinics
Of 2700 mothers enrolled in the study, 37 were excluded
from the analysis: 14 were tested but did not receive their
results, 20 were already known to be HIV-1 infected
prior to pregnancy, and three were tested at labour.
These mothers were excluded because their HIV-1 status
was not identified through the MCH system, which was
the focus of this study, or because they did not receive
results and would therefore not receive interventions.
Overall, 2453 (92.1%) mothers reported having received
HIV-1 results during pregnancy (Figure 1).
Compared with mothers who were tested, untested
mothers were younger (23.2 vs. 24.0 years, p = 0.039),
less educated (85.2% vs. 74.9% had less than secondary
education, p = 0.001), less likely to be married (79.5% vs.
86.7%, p = 0.004), and more likely to reside in Nyanza
(Table 2). Additionally, mothers not tested were more
likely to be of lower socio-economic status as indicated
by monthly rent ($18.60 vs. $22.80, p < 0.001), television
set ownership (31.9% vs. 46.1%, p < 0.001), or gas cooker
ownership (4.8% vs. 10.4%, p = 0.009). No significant dif-
ferences in employment status or parity were observed
between mothers tested and those not tested.
The proportion of mothers who would not buy food
from a person living with HIV/AIDS who was not visi-
bly sick did not differ significantly between tested and
untested mothers. However, there was a trend for
mothers who were not tested to not want to buy food
from a vendor who was visibly sick, although the
amount of difference was modest (52.6% vs. 45.9%, p =
0.06). Responses to measures of internal and enacted
stigma and rates of disclosure of HIV-1 status to partner
did not differ between tested and untested mothers. In
multivariate analysis, higher education (OR = 1.72, 95%
CI: 1.14-2.60, p = 0.009), socio-economic status (as mea-
sured by television set ownership) (OR = 1.43, 95% CI:
1.02-1.96, p = 0.03) and Nairobi Province (OR = 1.69,
95% CI: 1.26-2.27, p < 0.001) were found to be indepen-
dently associated with having been HIV-1 tested.
Table 1 Baseline characteristics of mothers in the cohort
Characteristic N (%), mean (95% CI)
Region Combined
N = 2700
Western
908 (33.6%)
Nairobi
1792 (66.4%)
Socio-demographic and economic
Age (years)** 24.0 (23.8-24.2) 23.3 (22.9-23.6) 24.3 (24.1-24.5)
Education lower than secondary level** 2043 (75.7%) 723 (79.6%) 1320 (73.7%)
Married (n = 2662)** 2294 (86.2%) 726 (81.5%) 1568 (88.5%)
Unemployed (n = 2698)** 1897 (70.3%) 598 (66%) 1299 (72.5%)
Economic ($) Monthly rent* (n = 2187)** 22.6 (21.9-23.2) 16.7 (15.2-18.2) 24.5 (21.923.2)
Own television** 1210 (44.8%) 316 (34.8%) 894 (49.9%)
Gas cooker** 267 (9.9%) 56 (6.2%) 211 (11.2%)
Obstetrics
Primiparous 987 (36.6%) 321 (35.4%) 666 (37.2%)
Utilization of antenatal and maternity services
Attend ANC** 2,638 (97.7%) 865 (95.3%) 1773 (98.9%)
Non-facility delivery (n = 2699)** 743 (27.5%) 340 (37.5%) 403 (22.5%)
SD - standard deviation
*Excludes mothers (especially in rural areas) who own their homes
**p value < 0.05
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were not tested despite having attended antenatal clinics
(ANCs); the remaining 56 had not attended antenatal
care clinics. Reasons why mothers did not attend ANCs
included competing time demands (30.4%), distance
(19.6%), cost (16.1%), lack of perceived need (19.6%), to
avoid HIV-1 testing (7.1%), being in school (7.1%), social
problems (3.6%), and attitudes of facility staff (3.6%).
Reasons why mothers who attended ANCs were not
tested included unavailability of services or failure of
staff to offer testing (43.5%) and slow service provision
(12.3%). Personal factors included need to consult part-
ner (13.6%), fear of results (12.3%), no perceived need
due to previous negative test (7.8%), and cost when
mothers visited private antenatal clinics (3.2%).
Utilization of PMTCT interventions by HIV-1-infected
women
Facility delivery
In total, 336 (13.7%) mothers were diagnosed antenatally
with HIV-1. HIV-1-positive mothers were more likely to
have a non-facility delivery than HIV-1-uninfected
mothers (31.0% vs. 24.3% p = 0.009) (Table 3). Among
HIV-1-infected mothers, those who did not deliver at a
health facility were less educated (91.4% vs. 75.9% had less
than secondary education, p = 0.001) and were of lower
socio-economic status. Age, marital status, parity and dis-
tance to the health facility did not differ between HIV-1-
infected women who delivered at a facility and those who
did not. There was a trend for mothers who did not deli-
ver in a health facility to report that people with HIV-1
should be ashamed. However, responses to other stigma
measures were comparable between mothers who deliv-
ered at a health facility and those who did not (Table 2).
In multivariate analysis, higher education (OR = 2.9, 95%
CI: 1.3-6.1, p = 0.007) and socio-economic status (as mea-
sured by television set ownership) (OR = 2.1, 95% CI: 1.2-
3.7, p = 0.006) were independently associated with facility
delivery in HIV-1-infected mothers.
The most common reason given for non-facility deliv-
ery was security concern when labour started at night
(25%). Other reasons given were distance (23.1%), cost
(17.3%), rapid progression of labour (17.3%), being alone
at home (3.8%) or failure to secure a vehicle (2.9%).
Only 5% of mothers stated a preference to be delivered
by a traditional birth attendant.
2700 enrolled 
2467 tested at ANC  233 not tested at ANC 
20 known HIV 
positive 
210 not tested 
154 attended 
ANC
56 did not 
attend ANC
14 did not 
receive results 
3 tested during labour 
2453 tested 
Figure 1 Antenatal HIV testing among mothers enrolled.
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Overall, 90% of HIV-1-infected mothers used PMTCT
antiretrovirals (ARVs) or gave infants ARVs. Maternal
ARVs were not dispensed to 10.7% of mothers, and of
those given drugs, 10.6% failed to take them. Among
infants, 15.7% were not dispensed ARVs, but only 2.2%
were not given if the drugs were dispensed. The 10% of
mothers who did not use maternal or infant ARVs were
more likely to have had a non-facility delivery (58.1% vs.
26.1%, p < 0.001) (Table 3). In addition, they were more
likely to report they thought HIV-1 was a punishment for
bad behaviour (58.6% vs. 37.8%, p = 0.030) and that peo-
ple with HIV-1 should be ashamed (22.6% vs. 5.3%, p <
0.001) (Table 3). In multivariate analysis, non-facility
delivery (OR = 0.28, 95% CI: 0.13-0.60, p = 0.001) and
thinking that people with HIV-1 should be ashamed (OR
= 0.22, 95% CI: 0.08-0.62, p = 0.004) were independently
associated with failure to use ARVs.
Infant feeding
Most (92.4%) HIV-1-infected mothers were feeding their
infants as recommended by WHO (exclusively breast-
feeding, replacement feeding, or wet nursing). The
majority (77.2%) reported exclusively breastfeeding.
Mothers who had disclosed their HIV-1 status to their
partners were more likely to feed their infants as recom-
mended (82.3% vs. 57.9%, p = 0.01).
Infant HIV-1 transmission
Of 336 HIV-1-exposed infants, HIV-1 DNA PCR results
were available for 300. Of these, seven (2.3%) had indeter-
minate results, 270 (90.0%) were HIV-1 uninfected and 23
(7.7%) were HIV-1 infected. Fifteen HIV-1 exposed infants
were not tested, 10 (66.7%) because they had a specimen
for the test taken at another facility. Mothers who did not
use antiretrovirals were more likely to transmit HIV-1 to
their infants (9.4% vs. 6.7%, p = 0.5). However, we were
not adequately powered to show a statistically significant
difference. Level of education, marital status, employment
status, place of delivery, parity and measures of the four
domains of HIV-1 stigma did not differ between mothers
of HIV-1-infected and uninfected infants.
Discussion
In Africa, where about 90% of the world’sn e wp a e d i a -
tric HIV-1 infections occur, attaining high PMTCT
Table 2 Comparison of selected characteristics among mothers tested for HIV-1 antenatally and those not tested
Antenatal HIV testing (n = 2663)
Characteristics Not tested
% mean
(95% CI)
210 (7.9%)
Tested
% mean
(95% CI)
2453 (92.1%)
P value
Socio-demographic and obstetrics
Age 23.2 (5.4) 24.0 (5.0) 0.039
Education lower than secondary level 179 (85.2%) 1836 (74.9%) 0.001
Married (n = 2629) 163 (79.5%) 2102 (86.7%) 0.004
Unemployed (n = 2661) 156 (74.3%) 1712 (69.9%) 0.177
Primiparous 73 (34.8%) 905 (36.9%) 0.539
Home delivery (n = 2662) 114 (54.3%) 620 (25.3%) < 0.001
Economic
Monthly rent in US$ (n = 2159) 18.6 (12.5) 22.8 (14.8) < 0.001
Own TV (n = 2663) 67 (31.9%) 1131 (46.1%) < 0.001
Gas cooker (n = 2663) 10 (4.8%) 255 (10.4%) 0.009
Stigma measures
Fear of casual transmission (n = 2660)
Not buy food from PLHIV* not visibly sick 49 (23.4%) 502 (20.5%) 0.310
Not buy food from PLHIV* visibly sick 110 (52.6%) 1125 (45.9%) 0.061
Internal stigma
HIV is punishment for bad behaviour (n = 2582) 115 (56.9%) 1225 (51.5%) 0.136
People with HIV should be ashamed (n = 2608) 25 (12.2%) 336 (14.0%) 0.477
Enacted sigma
Abandoned by spouse/partner (n = 2512) 96 (49.0%) 1142 (49.3%) 0.929
Disclosure
Disclosed HIV status to partner 2169 (94%) -
Region (n = 2663)
Nyanza (western Kenya) 99 (47.1%) 789 (32.2%) < 0.001
* PLHIV - people/person living with HIV/AIDS
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eradicating infant HIV-1 infection globally. In this study
of PMTCT delivery in Nairobi and western Kenya, we
found remarkably high coverage of PMTCT services in
six sampled public sector sites, with 92% of women
receiving antenatal HIV-1 testing, 90% of whom
received maternal or infant antiretrovirals. In contrast to
low global estimates of PMTCT coverage, the coverage
we found reflects expansion of PMTCT services in
Kenya and demonstrates much higher levels of ANC
testing and PMTCT services than in previous years; this
is consistent with promising recent reports from other
sub-Saharan African settings. As other settings seek to
i m p r o v eP M T C Tc o v e r a g e ,o u rs t u d yr e s u l t sa r e
encouraging and suggest that United Nations General
Assembly goals of 80% coverage are widely attainable.
While noting efficacy of the system, we identified
areas for further improvement. Of 2700 women
enrolled, 210 (7.9%) mothers were not tested for HIV-1,
missing an opportunity to access PMTCT interventions.
Most of these mothers had attended ANCs,
surmounting one of the traditional obstacles to PMTCT
access. The most common reason cited by mothers for
not testing was unavailability of HIV-1 testing services
at the ANC or failure of providers to offer testing. In
public facilities, this was possibly due to stock outs of
test kits. Private facilities may not have offered HIV-1
testing due to concerns that mothers would avoid facil-
ities that conduct HIV-1 testing. Another disincentive
for HIV-1 testing was time required for counselling
and/or testing services. Combined, these health-system
based factors contributed to about 60% of non-testing
among mothers who attended antenatal clinics.
Four domains of HIV-1 stigma were evaluated using
questions that had been tested and validated in Tanza-
nia [21,22]. These domains were: fear of casual trans-
mission and refusal of contact with people living with
HIV/AIDS; value- and morality-related attitudes of
blame, judgement and shame for those living with HIV/
AIDS; disclosure of HIV test results; and enacted stigma
or discrimination. Surprisingly, although stigma was pre-
valent, stigma measures did not differ significantly
Table 3 Correlates of facility delivery and use of antiretroviral drugs
Delivery (n = 336) ARV drug use (n = 318)
Non Facility
N%
Mean (95% CI)
104 (31%)
Facility
N%
Mean (95% CI)
232 (69.1%)
P value Did not use
N%
Mean (95% CI)
31 (9.8%)
Used
N%
Mean (95% CI)
287 (90.3%)
P value
Socio-demographic characteristics
Age 26.3 (25.2-27.4) 25.7 (25-26.3) 0.363 25.3 (23.6-27) 26 (25.3-26.6) 0.440
Lower than secondary education 95 (91.4%) 176 (75.9%) 0.001 24 (77.4%) 230 (80.1%) 0.720
Married 84 (86.6%) 194 (87.8%) 0.769 23 (79.3%) 240 (88.6%) 0.150
Unemployed 70 (67.3%) 154 (66.4%) 0.867 20 (64.5%) 191 (66.6%) 0.820
Primiparous 17 (16.4%) 59 (25.4%) 0.066 5 (16.1%) 67 (23.3%) 0.362
Home delivery - - - 18 (58.1%) 75 (26.1%) < 0.001
Distance to health facility 2.9 (2-3.8) 2.8 (2.3-3.3) 0.82 - - -
Economic
Monthly rent in US$ (n = 248) 13.0 (11.1-14.9) 23.7(21-26.3) < 0.001 14.2 (11-17.4) 22(19.7-24.3) < 0.001
Own TV 23 (22.1%) 95 (41.0%) 0.001 8 (25.8%) 106 (36.9%) 0.202
Gas cooker 2 (1.9%) 21 (9.1%) 0.018* 0 (0%) 23 (8.0%) 0.102
Stigma measures
Fear of casual transmission
Not buy food from PLHIV not visibly sick 12 (11.5%) 15 (6.5%) 0.114 2 (6.5%) 23 (8.0%) > 0.999*
Not buy food from PLHIV visibly sick 28 (26.9%) 56 (24.1%) 0.586 10 (32.3%) 69 (24.0%) 0.315
Internal stigma
HIV is punishment for bad behaviour 44 (46.3%) 82 (38.0%) 0.167 17 (58.6%) 101 (37.8%) 0.030
People with HIV should be ashamed 12 (11.7%) 13 (5.7%) 0.056 7 (22.6%) 15 (5.3%) < 0.001
Enacted sigma
Abandoned by spouse/partner 47 (48.0%) 123 (54.2%) 0.302 13 (46.4%) 148 (53.1%) 0.504
Disclosure
Disclosed HIV status to partner 72 (81.8%) 159 (81.1%) 0.889 20 (87.0%) 196 (80.0%) 0.584
Region
Nyanza (western Kenya) 56 (53.9%) 112 (48.3%) 0.345 15 (48.4%) 142 (49.5%) 0.908
* Fischer’s exact test
Kinuthia et al. Journal of the International AIDS Society 2011, 14:61
http://www.jiasociety.org/content/14/1/61
Page 6 of 9between women who were HIV-1 tested and those who
were not, suggesting a diminishing role of stigma as a
barrier to HIV-1 testing at ANC clinics. This may be
due to successful “opt-out” approaches, which seek to
routinize and de-stigmatize HIV-1 testing [13,14]. We
found that mothers with lower education, from Nyanza
Province and those of lower socio-economic status were
less likely to have been tested. Women of lower socio-
economic status face constraints, including transport
costs to access services. We found the most common
reason given by mothers for failure to attend antenatal
clinics was competing time demands.
HIV-1 testing in pregnancy is ultimately futile in pre-
venting infant HIV-1 if mothers do not use PMTCT
interventions. In this study, 336 mothers were identified
antenatally as HIV-1 infected. Of these, 104 (31%) did
not deliver at a health facility. Facility delivery offers
opportunity to prevent prolonged labour and rupture of
membranes, both contributing factors to transmission of
HIV-1 [23,24]. Additionally, facility delivery facilitates
use of ARVs. Although the proportion of non-facility
delivery we recorded was lower than the 56% reported
by the Kenya Demographic Health Survey in the general
population [20,25], it was of concern that HIV-1-
infected mothers were significantly less likely to deliver
at facilities than HIV-1-uninfected mothers. Most impe-
diments cited by mothers for not delivering at facilities
could be overcome if programmes incorporated birth
preparedness interventions [26]. During antenatal care,
PMTCT providers should assist mothers to plan for
birth, educate mothers to recognize signs of labour, and
help them plan for transport to the facility [26].
In 2009, global estimates suggested that almost half of
pregnant HIV-1-infected women in sub-Saharan Africa
did not receive ARVs [2]. Home delivery, low levels of
education, being unmarried, non-disclosure of test
results, few antenatal care visits, and poor interactions
with healthcare providers have been reported as barriers
to use antiretrovirals for PMTCT [27-31]. In our study,
although 90% of mother-infant pairs received maternal
or infant ARVs, 20% of mothers and 17% of infants did
not use ARVs.
We identified two barriers to use of ARVs. First, about
10% of mothers and 15% of infants were not given
ARVs despite attending antenatal clinics and being iden-
tified as HIV-1 infected. Second, mothers who did not
deliver at a health facility were less likely to use ARVs,
similar to reports in other studies [27,28,32,33]. When
mothers received ARVs, self-reported adherence was
high. Almost 90% of mothers reported using maternal
dose and 97.7% reported giving the drugs to their
infants, comparable with other studies [28,29]. Among
the 10% of mothers who did not take maternal or infant
ARVs, internal stigma indicators were significantly
higher, suggesting that stigma may have compromised
this minority of women. Determining strategies to pre-
serve confidentiality while delivering ARVs in this group
of women may be useful to increase uptake beyond 90%.
Most mothers in our study reported exclusively
breastfeeding as recommended by WHO [34]. Exclusive
breastfeeding confers a lower risk of HIV-1 transmission
than mixed feeding [35]. The 2008 Kenya Demographic
Health Survey reported that only 35% of infants younger
than three months exclusively breastfed [20]. Encoura-
gingly, we found prevalence of mixed feeding at six
w e e k sw a s7 . 6 % .T h i ss u g g e s t st h a tm e s s a g e so ne x c l u -
sive breastfeeding are being translated into practice. We
found that mothers who had not disclosed their HIV-1
status to their partners were more likely to mixed feed,
underscoring the importance of facilitating disclosure of
HIV-1 status to partners.
The HIV-1 transmission risk in this study was 7.7%.
This included women who did not attend antenatal care
and is considerably lower than expected without
PMTCT interventions (about 20%). Overall, it reflects
high coverage and uptake of PMTCT at these sites and
as more comprehensive PMTCT interventions are
implemented, the infant HIV-1 transmission risk would
be expected to decrease further. Infant HIV-1 infection
risk was not associated with socio-demographic or
stigma variables, suggesting that if systems are built,
women will come for testing and infants will be spared
HIV-1 infection despite a variety of potentially daunting
social constraints. Our findings are consistent with data
from a study in KwaZulu-Natal, South Africa, that simi-
larly tested infants brought for immunization at six
weeks of age [36]. Both studies offer objective evaluation
of programme effectiveness.
This study had several strengths. Through targeting
mothers who brought their infants for immunizations at
six weeks, we were able to access both mothers who
had utilized antenatal care and those who did not. At
six weeks postpartum, HIV-1 testing, delivery, ARV uti-
lization and choice of infant feeding would all have been
implemented. Therefore, it was possible to assess utiliza-
tion of PMTCT interventions during antenatal, intrapar-
tum and postpartum periods and to include assessment
of infant HIV-1 as an outcome of programme success.
Importantly, in contrast with previous studies, we sys-
tematically ascertained stigma indicators to probe
whether these were associated with intervention uptake
and with infant HIV-1.
Limitations of the study included purposive rather
than random selection of clinics, which theoretically
limits generalizability. The study was designed with an
estimate that 10% of mothers would not have attended
antenatal clinics [25]; however, we found that only 2.3%
of mothers had not received antenatal care. One benefit
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was that it allowed us to comprehensively probe barriers
to PMTCT delivery within the system. However, the
study did not assess mothers who did not bring their
children for immunizations and who may have also
been less likely to have accessed PMTCT.
In summary, the PMTCT coverage we observed in
routine national programmes was encouragingly high.
There were missed opportunities in HIV-1 testing,
ARVs and facility delivery that modestly lowered the
effectiveness of the PMTCT programme. Overall, health
systems factors rather than stigma were barriers to utili-
zation of PMTCT services. With more effective PMTCT
regimens, as recommended in the recent WHO guide-
lines, even lower infant HIV-1 risk would be expected in
the future. Despite considerable perceived stigma,
women access and comply with PMTCT interventions.
Thus, efficient PMTCT service delivery has the potential
to rapidly and substantially diminish the paediatric HIV-
1 epidemic in Africa.
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